Using the social ecologic framework to improve the influenza vaccination strategy among the Portuguese elderly by Machado, Ausenda et al.
before and after onset of the service with a 3- month phase-
in period, using segmented linear regression with 9-month
(April 2014- December 2014) pre- and 36-month (April 2015-
March 2018) post- intervention periods. Rate of GP interac-
tions were similarly compared before and after using 21-
month pre- and 36-month post- intervention periods. Rates of
A&E presentations and GP interactions for practice population
in Drumchapel- an area within NHS Greater Glasgow &
Clyde with similar rates of deprivation, but with no such serv-
ice in place - were used as a comparison group. Autoregres-
sive and moving average terms and a fourier term to adjust
for seasonality were included in the models.
Results Govan practices had a lower rate of A&E presenta-
tions than Drumchapel practices across all time points. A&E
presentations did not change significantly over time between
April and December 2014 in either area. At April 2015, SHIP
onset, a level change of -4.34 (-7.44, -1.24) A&E presenta-
tions was observed in both areas, but no significant change in
trend over time comparing pre and post SHIP in either area.
Onset of SHIP was therefore not associated with a reduction
in level or trend in A&E presentations. Rate of interactions
with GP was greater for the Govan practices than those of
Drumchapel at all time points, prior to January 2015, increas-
ing over time in both areas. After April 2015, there was a sig-
nificant level change of 33.78 (19.57, 47.99) per 1000 in
both areas. GP interactions in Govan however saw a signifi-
cant reduction of -1.48 (-2.87, -0.09) per 1000 per month,
following onset of SHIP, between April 2015 and March
2018. This is equivalent to SHIP being associated with an
absolute reduction of 37 GP interactions per thousand and a
relative reduction of 7.2% by March 2018.
Conclusion The Govan SHIP initiative was associated with no
significant change in A&E presentations and a small reduction
in GP interactions. A cost effectiveness analysis is
recommended.
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Background Ensuring academic research leads to research that
is useful for end users is a key challenge in the health
research arena. Stakeholder engagement is being increasingly
recognised as an important way to achieving impact. The
workHORSE project was designed to continuously engage
with stakeholders, via four iterative workshops and an e-plat-
form, to inform the development of an open source/open
access modelling tool to enable commissioners to quantify the
potential cost-effectiveness and equity of the NHS Health
Check Programme. An objective of the project is to evaluate
the involvement of stakeholders in the process of building the
workHORSE computer modelling tool.
Methods The design of the workshop programme was theory-
based using the Cairney/Oliver key co-production principles.
We identified stakeholders using our extensive networks and
snowballing techniques. Iterative development of the decision
support modelling tool was informed through engaging with
stakeholders during three workshops (to date). We used
detailed scripts facilitating open discussion and opportunities
for stakeholders to provide additional feedback subsequently.
At the end of each workshop, stakeholders completed stake-
holder engagement questionnaires to explore their views and
experiences throughout the process. The research team also
completed questionnaires to explore their expectations prior
to the workshops and their experiences thereafter.
Results A total of 25 stakeholders have participated, of which
11 attended two or more workshops. They spanned all levels:
local (NHS commissioners, GPs, local authorities and academ-
ics), third sector and national organisations (including Public
Health England).
Stakeholders experiences were positive overall. They felt
valued and commended the involvement of practitioners.
Major reasons for attending included being able to influence
development and having insight and understanding of what
the tool could include and how it would work in practice.
They appreciated the iterative process involving a series of
workshops which provided opportunities for them to learn
about and reflect upon the model’s capacity, usage and useful-
ness. Researchers saw the process as an opportunity for devel-
oping a common language and trust in the end product and
ensuring the support tool was transparent. The workshops
have acted as a reality check ensuring model scenarios and
outputs are relevant and fit for purpose.
Conclusion Computational modellers rarely consult with end
users when developing tools to inform decision-making. The
added value of co-production (collaboration and iteration with
stakeholders) potentially enables modellers to produce a ‘real-
world’ operational tool. Likewise, stakeholders have increased
confidence in the decision support tool’s development and
applicability in practice.
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Background In a context of lower than targeted influenza vac-
cination (IV) coverage, identifying factors associated IV uptake
is essential to improve population coverage. Although exten-
sive work has been done in this field, scarcer studies focused
on framing these factors within a multifactorial model. Having
the social ecological model (SEM) as framework, this study
intended to identify and quantify the SEM levels associated to
seasonal IV uptake in the Portuguese population aged 65 and
more years.
Methods Data from the Portuguese 2014 National Health Sur-
vey was restricted to individuals aged 65 and more years
(n=5669). The outcome of interest was self-reported IV
uptake in the 2 years previous to the interview. Twenty three
independent variables were selected from the survey and were
allocated in one of the five SEM levels: individual, interperso-
nal, organizational, community and policy. Sex stratified and
age adjusted analysis using Poisson regression were performed
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for each SEM level. To evaluate statistical significance and
marginal contribution of each SEM level for explaining IV
uptake, the full model was fitted (all variables from all 5
SEM levels). To determine joint statistical significance of varia-
bles of each SEM level, the model without respective SEM
level was compared with the full model using likelihood ratio
test. Additionally, marginal contribution of each SEM level
was measured by relative reduction in magnitude of pseudo R
square.
Results For both men and women, older age groups (85 or
more vs 65–69 age group; PR=1.59 for men and PR=1.56
for women); having 3 or more chronic conditions (PR=1.39
for men and PR=1.35 for women); number of GP and outpa-
tient visits in the previous 4 weeks were associated to higher
IV uptake. For men, only 2 out of the 5 SEM levels were
associated to IV uptake (individual and organizational). For
women 3 levels were relevant for this preventive measure
(individual, organizational and community). Main marginal
contribution for explaining the IV uptake, came from individ-
ual (17.9% and 16.3%) and organizational (30.7% and
22.7%) levels for both men and women respectively.
Conclusion Besides individual characteristics, like age and
health status - known determinants of IV uptake - this study
highlights the importance of access and use of health care
services for adoption of IV preventive measure. Moreover, it
evidences a sex differential behaviour that should be
accounted in the definition of the IV campaign strategy.
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Background Electronic health records use clinical codes to
classify disease and conditions, not disability (how impairment
affects human function). Codes for the degree of disability are
not routinely recorded alongside the diagnosis, unless part of
the diagnostic code e.g. profound learning disability. Existing
strategies identify conditions associated with disability, prioritis-
ing either identifying every person with possible or highly
probable disability to limit type I (false positive) or type II
(false negative) misclassification error.
In high income countries, 1–4% of children have develop-
mental disabilities. They can be diagnosed before the age of
five but, in practice, developmental delay is often diagnosed
and the disabling condition (e.g. autism spectrum disorders or
cerebral palsy) diagnosed when the child is older. Diagnoses
of both delay/generalised developmental disorders and a dis-
abling condition diagnosis could indicate disability severity. Is
a sensitive or specific strategy or a combination of both neces-
sary to obtain a realistic estimate of developmental disability
prevalence in preschool children?
This study aimed to develop and compare strategies to
identify children with possible and probable developmental
disabilities diagnosed before the age of five in primary care
data.
Methods Two case ascertainment strategies were developed
and the primary care records of children in the Born in
Bradford (BiB) cohort study (from birth to their fifth birthday)
searched: 1) to identify children with conditions associated
with substantial developmental disability (autism spectrum dis-
orders, Down syndrome and cerebral palsy and moderate-pro-
found learning disability); and 2) to identify children with
indicators of developmental disability (developmental delay,
generalised developmental disorders, mild and unknown
severity learning disability).
Results The combined UK prevalence of the disabling condi-
tions is 417 per 10,000 children below age 18. The preva-
lence in the study sample (n=9,727) was 85 per 10,000
(n=47 autism spectrum disorders, n=24 Down syndrome,
n=12 cerebral palsy). None had moderate-profound learning
disability. Half also had disability indicators (53%, n=44). The
prevalence of disability indicators was 450 per 10,000
(n=438). Of those with only indicators (n=394), 75.9% had
a single indicator. The most common indicators in both the
condition and indicator groups were speech delay, develop-
mental delay and developmental language delay.
Conclusion Using only disabling condition clinical codes for
case ascertainment via primary care data is likely to greatly
underestimate disability prevalence in children under the age
of five. Where independent disability verification is not possi-
ble, the number of disability indicators may reflect disability
severity.
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Background Annual gains in life expectancy in Scotland have
been slower in recent years than in the previous two decades
for males and females. Similar slowdowns or even reversals
have been observed in England, Wales, Northern Ireland and
the USA. This contribution explores the contribution of spe-
cific causes of death to the changes in mortality by age and
cause for two time periods: 2000–02 to 2012–14 and 2012–
14 to 2015–17.
Methods Life expectancy at birth was calculated from death
and population counts available from National Records of
Scotland (NRS), disaggregated by five year age categories and
by ICD-10 underlying cause of death. Arriaga’s method of life
expectancy decomposition was applied to produce estimates of
the contribution of different age groups and underlying causes
of death to life expectancy at birth in each of the two
periods.
Results Life expectancy trends deteriorated after 2012–14 and
life expectancy subsequently fell. The worsening trend
involved increased inequalities as it was more profound with
increasing area deprivation. Almost all age groups saw a wor-
sening of trends in the later time periods and this was also
seen across almost all causes of death. In particular, the previ-
ously observed rapid improvements in circulatory causes which
benefited those aged 55–84 years most, more than halved.
There were also absolute increases in mortality rates for those
aged 35–49 years due in large part to increases in drug-
related deaths; and amongst those aged 90+ years due to
increased mortality from dementia/Alzheimer’s.
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